Biopharmaceutical Classification System (BCS) and Bioavailability Enhancement: CDMO Insights
The Biopharmaceutical Classification System (BCS) categorizes drugs based on their solubility and permeability characteristics, providing valuable insights into their potential bioavailability challenges and formulation strategies. Contract Development and Manufacturing Organizations (CDMOs) leverage their expertise to enhance the bioavailability of drugs classified under various BCS categories.https://renejix.com/formulatio....n-technologies/bioav
Like
Comment
Share
